Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues
- PMID: 28144997
- PMCID: PMC6529062
- DOI: 10.1111/cpr.12334
Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues
Abstract
Mesenchymal stem cell (MSC) research progressively moves towards clinical phases. Accordingly, a wide range of different procedures were presented in the literature for MSC isolation from human tissues; however, there is not yet any close focus on the details to offer precise information for best method selection. Choosing a proper isolation method is a critical step in obtaining cells with optimal quality and yield in companion with clinical and economical considerations. In this concern, current review widely discusses advantages of omitting proteolysis step in isolation process and presence of tissue pieces in primary culture of MSCs, including removal of lytic stress on cells, reduction of in vivo to in vitro transition stress for migrated/isolated cells, reduction of price, processing time and labour, removal of viral contamination risk, and addition of supporting functions of extracellular matrix and released growth factors from tissue explant. In next sections, it provides an overall report of technical highlights and molecular events of explant culture method for isolation of MSCs from human tissues including adipose tissue, bone marrow, dental pulp, hair follicle, cornea, umbilical cord and placenta. Focusing on informative collection of molecular and methodological data about explant methods can make it easy for researchers to choose an optimal method for their experiments/clinical studies and also stimulate them to investigate and optimize more efficient procedures according to clinical and economical benefits.
Keywords: cytokines; explant culture method; growth factors; human tissue; mesenchymal stem cells; non-enzymatic.
© 2017 John Wiley & Sons Ltd.
Conflict of interest statement
There is no conflict of interest. There is no grant or funding support for this manuscript.
Figures




References
-
- Hendijani F, Javanmard SH. Dual protective and cytotoxic benefits of mesenchymal stem cell therapy in combination with chemotherapy/radiotherapy for cancer patients. Crit Rev Eukaryot Gene Expr. 2015;25:203–207. - PubMed
-
- Hendijani F, Javanmard SH, Sadeghi‐aliabadi H. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin. Tissue Cell. 2015;47:229–234. - PubMed
-
- AL‐Qaisy BA, Yousif Yaseen N, Alwachi SN, AL‐Shammari AM. Comparison between three different protocols for isolation and culture of mouse bone marrow derived mesenchymal stem cells. Iraqi J Cancer Med Genet. 2014;7:26–35.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources